A detailed history of Mariner, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mariner, LLC holds 1,359,073 shares of PFE stock, worth $35.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,359,073
Previous 1,370,237 0.81%
Holding current value
$35.8 Million
Previous $38.3 Million 2.59%
% of portfolio
0.07%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $309,242 - $350,437
-11,164 Reduced 0.81%
1,359,073 $39.3 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $708,037 - $829,688
28,030 Added 2.09%
1,370,237 $38.3 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $535,223 - $614,608
20,673 Added 1.56%
1,342,207 $37.2 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $4.14 Million - $5.38 Million
-158,500 Reduced 10.71%
1,321,534 $38 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $19.1 Million - $22.3 Million
-595,593 Reduced 28.69%
1,480,034 $49.1 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $1.41 Million - $1.63 Million
39,021 Added 1.92%
2,075,627 $76.1 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $8.33 Million - $10.8 Million
-211,401 Reduced 9.4%
2,036,606 $83.1 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $12.9 Million - $16.9 Million
309,653 Added 15.98%
2,248,007 $115 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $4.11 Million - $5.01 Million
93,867 Added 5.09%
1,938,354 $84.8 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $21.7 Million - $25.8 Million
466,952 Added 33.9%
1,844,487 $96.7 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $9.66 Million - $12 Million
211,192 Added 18.11%
1,377,535 $71.3 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $7.34 Million - $10.9 Million
177,548 Added 17.96%
1,166,343 $68.9 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $4.88 Million - $6.26 Million
124,214 Added 14.37%
988,795 $42.5 Million
Q2 2021

Aug 24, 2021

BUY
$35.91 - $40.68 $2 Million - $2.26 Million
55,612 Added 6.87%
864,581 $33.9 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $1.11 Million - $1.25 Million
33,015 Added 4.25%
808,969 $29.3 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $2.36 Million - $3 Million
70,528 Added 10.0%
775,954 $28.6 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $1.04 Million - $1.22 Million
32,810 Added 4.88%
705,426 $25.9 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $685,350 - $831,431
22,754 Added 3.5%
672,616 $22 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $1.29 Million - $1.84 Million
47,753 Added 7.93%
649,862 $21.2 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $1.25 Million - $1.42 Million
37,985 Added 6.73%
602,109 $23.6 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $16.1 Million - $20.8 Million
-494,332 Reduced 46.7%
564,124 $20.3 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $137,713 - $154,620
3,724 Added 0.35%
1,058,456 $45.9 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $11.3 Million - $12.4 Million
301,527 Added 40.03%
1,054,732 $34.7 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $13.1 Million - $14.9 Million
340,506 Added 82.51%
753,205 $32.8 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $165,249 - $200,437
4,794 Added 1.18%
412,699 $18.2 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $3.73 Million - $3.97 Million
113,004 Added 38.32%
407,905 $14.8 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $19,433 - $22,545
609 Added 0.21%
294,901 $10.5 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $1.75 Million - $1.86 Million
52,655 Added 21.79%
294,292 $10.7 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $7.49 Million - $8.25 Million
241,637
241,637 $8.63 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.